Sacha, Tomasz

• Vol 49, No 3 (2018) - Praca Oryginalna/Original Research Article
  Wykrywanie mutacji w genie oraz w genie u chorych na nadpłytkowość samoistną i samoistne włóknienie szpiku przy pomocy sekwencjonowania Sangera oraz analizy długości fragmentów DNA
  Abstract  PDF (Polish)
• Vol 49, No 3 (2018) - Praca Oryginalna/Original Research Article
  Znaczenie badań molekularnych dla oceny ryzyka i rokowania u chorych na pierwotne włóknienie szpiku w oparciu o wskaźniki prognostyczne IPSS, DIPSS oraz MIPSS
  Abstract  PDF (Polish)
• Vol 43, No 4 (2012) - Untitled
  Early hematopoietic chimerism monitoring and molecular engraftment characteristic by STR-PCR method in patients after alloHSCT
  Abstract  PDF (Polish)
• Vol 47, No 3 (2016) - Prace poglądowe / Reviews
  Recommendations for assessment of co-morbidities and tyrosine kinase inhibitor choice in patients suffering from chronic myeloid leukemia
  Abstract  PDF (Polish)
• Vol 47, No 3 (2016) - Prace oryginalne / Original research articles
  Retrospective analysis of nilotinib and dasatinib efficacy in second line treatment of chronic myeloid leukemia in Polish hematological centers
  Abstract  PDF (Polish)
• Vol 44, No 4 (2013) - Prace poglądowe / Reviews
  Polish Adult Leukemia Group Recommendations for Diagnosis and Treatment of Chronic Myeloid Leukemia in 2013
  Abstract  PDF (Polish)
• Vol 47, No 2 (2016) - Prace poglądowe / Reviews
  Recent developments in diagnostics and monitoring of tyrosine kinase inhibitors treatment response of chronic myeloid leukemia
  Abstract  PDF (Polish)
• Vol 47, No 2 (2016) - Prace poglądowe / Reviews
  Ponatinib in therapy of chronic myeloid leukemia and Philadelphia positive acute lymphoblastic leukemia
  Abstract  PDF (Polish)
• Vol 47, No 4 (2016) - Errata / Erratum
  Retrospective analysis of nilotinib and dasatinib efficacy in second line treatment of chronic myeloid leukemia in Polish hematological centers [Acta Haematologica Polonica 2016; 47(3): 219–225]
  Details  PDF (Polish)
• Vol 48, No 4 (2017) - Prace poglądowe / Reviews
  Efficacy and safety of bosutinib in the second and third line of treatment in chronic myeloid leukemia
  Abstract  PDF
• Vol 46, No 4 (2015) - Prace poglądowe / Reviews
  Nilotinib and dasatinib – current place in the therapy of chronic myeloid leukemia
  Abstract  PDF (Polish)